201-229

201. Brugada R, Hong K, Dumaine R, et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 2004; 109: 30-35.

202. Bellocq C, van Ginneken AC, Bezzina CR, et al. Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 2004; 109: 2394-

2397.

203. Leenhardt A, Lucet V, Denjoy I, et al. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation

1995; 91: 1512-1519.

204. Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular

tachycardia. Circulation 2002; 106: 69-74.

205. Viatchenko-Karpinski S, Terentyev D, Gyorke I, et al. Abnormal calcium signaling and sudden cardiac death associated with mutation of

calsequestrin.Circ Res 2004; 94: 471-477.

206. Benson DW, Wang DW, Dyment M, et al. Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene

(SCN5A). J Clin Invest 2003; 112: 1019-1028.

207. Veldkamp MW, Viswanathan PC, Bezzina C, et al. Two distinct congenital arrhythmias evoked by a multidysfunctional Na (+) channel. Circ Res

2000; 86: E91-97.

208. Baroudi G, Chahine M. Biophysical phenotypes of SCN5A mutations causing long QT and Brugada syndromes. FEBS Lett 2000; 487: 224-228.

209. Rivolta I, Abriel H, Tateyama M, et al. Inherited Brugada and long QT-3 syndrome mutations of a single residue of the cardiac sodium channel confer

distinct channel and clinical phenotypes. J Biol Chem 2001; 276: 30623-30630.

210. Bezzina C, Veldkamp MW, van Den Berg MP, et al. A single Na (+) channel mutation causing both long-QT and Brugada syndromes. Circ Res 1999;

85: 1206-1213.

211. Grant AO. Molecular biology of sodium channels and their role in cardiac arrhythmias. Am J Med 2001; 110: 296-305.

212. Viswanathan PC, Balser JR. Inherited sodium channelopathies: a continuum of channel dysfunction. Trends Cardiovasc Med 2004; 14: 28-35.

213. Tan HL, Bink-Boelkens MT, Bezzina CR, et al. A sodiumchannel mutation causes isolated cardiac conduction disease. Nature 2001; 409: 1043-1047.

214. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104: 545-556.

215. Hansson JH, Nelson-Williams C, Suzuki H, et al. Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic

heterogeneity of Liddle syndrome. Nat Genet 1995; 11: 76-82.

216. Hansson JH, Schild L, Lu Y, et al. A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle

syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc Natl Acad Sci U S A. 1995; 92: 11495-11499.

217. Schild L, Canessa CM, Shimkets RA, et al. A mutation in the epithelial sodium channel causing Liddle disease increases channel activity in the

Xenopus laevis oocyte expression system. Proc Natl Acad Sci U S A. 1995; 92: 5699-5703.

218. Mune T, Rogerson FM, Nikkila H, et al. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase.

Nat Genet 1995; 10: 394-399.

219. Abbott EC, Gornall AG, Sutherland DJ, et al. The influence of a heparin-like compound on hypertension, electrolytes and aldosterone in man. Can

Med Assoc J 1966; 94: 1155-1164.

220. Sutherland DJ, Ruse JL, Laidlaw JC. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can

Med Assoc J 1966; 95: 1109-1119.

221. Lifton RP, Dluhy RG, Powers M, et al. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone

synthase. Nat Genet 1992; 2: 66-74.

222. Wilson FH, Disse-Nicodeme S, Choate KA, et al. Human hypertension caused by mutations in WNK kinases. Science 2001; 293: 1107-1112.

223. Mansfield TA, Simon DB, Farfel Z, et al. Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoal-dosteronism type II, to

chromosomes 1q31-42 and 17p11-q21. Nat Genet 1997; 16: 202-205.

224. Geller DS, Farhi A, Pinkerton N, et al. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 2000; 289:

119-123.

225. Wilson FH, Hariri A, Farhi A, et al. A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 2004; 306: 1190-1194.

226. Choi M, Scholl UI, Yue P, et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 2011; 331:

768-772.

227. Shea S, Ottman R, Gabrieli C et al. Family history as an independent risk factor for coronary artery disease. J Am Coll Cardiol 1984; 4; 793-801.

228. Rissanen AM. Familial occurrence of coronary heart disease: effect of age at diagnosis. Am J Cardiol 1979; 44: 60-66.

229. The international HapMap Consortium. The international HapMap Project. Nature 2003; 426: 789-796.

文献